Allosteric covalent inhibition of cereblon through cryptic cysteine targeting
Preprint
Abstract
Thalidomide-derived cereblon (CRBN) modulators are among the most clinically impactful targeted protein degradation therapeutics, redirecting the CRL4-CRBN E3 ubiquitin ligase to degrade disease-driving neosubstrates. All current CRBN-targeting IMiDs and CELMoDs engage a single orthosteric pocket, leaving CRBN’s conformational landscape largely unexploited pharmacologically. Using cysteine-directed chemoproteomic screening, we identified covalent ligands that engage Cys287, a cryptic allosteric pocket distal to the orthosteric site. Our lead compound, VVD-105917, acts as a pan-inhibitor of IMiD/CELMoD-driven neosubstrate degradation. Cryo-EM structures reveal that covalent Cys287 engagement traps CRBN in its open, inactive conformation, resolving a previously unobserved N-terminal segment and sensor loop. Sequential incubation experiments show the conformational outcome depends on ligand addition order, demonstrating that even potent CELMoD-driven closure can be overridden by allosteric engagement. A recently reported ligand at this same pocket produces the opposite effect, promoting rather than blocking closure, indicating the Cys287 site is mechanistically sign-switchable. These findings establish covalent chemoproteomics as a strategy for discovering and controlling E3 ligase conformational switches.Keywords
Funding Information
- NIH (GM143805)
This publication has 26 references indexed in Scilit:
- Illuminating ubiquitination mechanisms: How cryo-EM has shed light on Cullin RING E3 ligase functionCurrent Opinion in Structural Biology, 2025
- BPS2025 - EMReady2: A general model for improving cryo-EM and cryo-ET maps by heterogeneity-aware deep learningBiophysical Journal, 2025
- Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the ClinicBiochemistry, 2022
- One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRASJournal of Medicinal Chemistry, 2021
- Setting Up Parallel Illumination on the Talos Arctica for High-Resolution Data Collection2020
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- In This IssueProtein Science, 2020
- Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligaseNature, 2016
- Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomideNature, 2014
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004